A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Daver N 

PROVIDER: S-EPMC8252033 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature